Cidara Therapeutics, Inc.CDTXNASDAQ
LOADING
|||
ROE: Returns Declining
Trending lower, below historical average, strong compound growth.
Left:
||||
Return on equity
Latest
-103.99%
↓ 22% below average
Average (9y)
-84.92%
Historical baseline
Range
High:279.31%
Low:-672.99%
CAGR
+14.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -103.99% | -137.2% |
| 2023 | 279.31% | +20.1% |
| 2022 | 232.61% | +218.2% |
| 2021 | -196.85% | +70.7% |
| 2020 | -672.99% | -519.6% |
| 2019 | -108.61% | -8.8% |
| 2018 | -99.79% | -7.0% |
| 2017 | -93.28% | -70.8% |
| 2016 | -54.62% | -76.3% |
| 2015 | -30.98% | - |